Coronavirus

The 2019 coronavirus (COVID-19) pandemic, caused by the SARS-CoV-2 novel virus, originated in Wuhan, China before rapidly spreading around the world.


COVID-19 is a highly infectious respiratory disease, with a high rate of transmissibility. Symptoms of infection include fever, joint and muscle aches, respiratory distress, loss of the sense of taste, cognitive fog, fatigue, sore throat, and more. Senior citizens are most at risk of dying from the disease, though secondary pre-existing conditions like obesity can make some patients more susceptible to danger. In severe cases, patients undergo respiratory distress and require intubation on ventilators. 


In response to the coronavirus pandemic, governments have initiated several policies to prevent spread. Many countries have severely restricted flights or entry into their state, with some like Israel adopting color systems to rank the risk posed by each destination. Contact tracing has become the norm, with citizens being obligated to quarantine after they have come into contact with an infected person. Social distancing and mask mandates have also become popular in many countries to prevent spread of infection. Early in the pandemic, lockdowns were used to prevent interaction between the public, in a severe attempt to halt transmission. Perhaps most controversial were the introduction of coronavirus passports, which would allow vaccinated citizens to move freely with a new form of ID. Critics assert that coronavirus passports represent an extreme violation of liberties.


There is an ongoing debate as to the origin of the coronavirus. Initially, it was accepted that the coronavirus originated in a wet market in Wuhan, China, within bats sold as food. However, it has been suggested that the virus may have originated from a virus research lab in Wuhan.


Several pharmaceutical companies have developed innovative mRNA vaccines to counter the coronavirus. Pfizer, Biontech, Astrazeneca, Moderna, Sinopharm and others have produced vaccines, however there is ongoing debate about their efficacy against new strains of the virus. Other pharmaceutical companies have developed treatments and drugs to alleviate and combat coronavirus symptoms.


The coronavirus is prone to mutations, and has already produced several well known variants, including the Delta and Lambda strains. The pandemic and virus may also colloquially be known as corona and COVID.

Read More
Less

How to stop worrying and learn to love the lockdown - opinion

Eternal optimists that we are, we believe with a full faith that humanity will survive and the world will return to a new normal.

A health worker is seen preparing to administer the a third COVID-19 booster shot (illustrative).

Omicron: UKHSA finds boosters provide 95% protection against death

For Moderna, effectiveness against hospitalization was 90-95% up to 9 weeks after the booster.

By REUTERS
27/01/2022

Partygate: Boris Johnson's Benjamin Netanyahu moment - analysis

Both Netanyahu and Johnson are known as savvy political operators who have gotten out of countless crises before. And both may be nearing the end of the line. 

27/01/2022

COVID-19 test fits in a backpack, is accurate, non-invasive and costs $51 - study

The kit is not based on a PCR test, the most commonly used test for COVID-19, but is based on a LAMP test, a widely accepted alternative with similar sensitivity. 

27/01/2022

COVID-19 in Israel: Hospitals under strain as schools remain open

Hospitals across Israel report strain on medical workers as Omicron cases rise * Children begin first school day under new isolation policy * 3 million antigen kits to be distributed to kindergardens

Is COVID-19 a ‘black swan’ for global tourism industry?

Culture, recreation, and tourism have become critical and inseparable elements of our lives.

By Dr. Shahar Shilo
26/01/2022

Educational initiative brings destroyed Holocaust communities to life

The purpose of the WikiShtetl project is “to encourage teachers and students to research communities that were destroyed during the Holocaust."

COVID-19 highlights Israel's need to invest in healthcare - editorial

There’s not a person in the country that doesn’t rely on the healthcare system to provide the best care possible.

Fauci says 'prudent' to have Omicron vaccine, but may not be needed

Pfizer/BioNTech said they have started clinical trials for a version of their vaccine targeting the highly-transmissible variant.

By REUTERS
25/01/2022

Seven signs that you may have already had coronavirus

Here's how to know if you’ve already been sick and recovered from the novel coronavirus.

By Walla!
25/01/2022
Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy